Vext Science(OTC) VEXTF

Market Cap$34.37M

Since IPO (2019)-87%

5 Year-69%

1 Year-0%

1 Month+13%

$0.19

+4.99%

+0.01Today

Vext Science last closing stock price
Metric	Price	Date
Last close	USD 0.19	2026-08-11

Vext Science stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+4.05%	USD 0.18	2026-08-04
1 month	+12.8%	USD 0.16	2026-07-10
3 month	-12.9%	USD 0.21	2026-05-13
Year to date	-2.63%	USD 0.19	2025-12-31
1 year	-0.48%	USD 0.19	2025-08-11
3 year	-2.63%	USD 0.19	2023-08-11
5 year	-68.74%	USD 0.59	2021-08-12
Since inception	-87.09%	USD 1.43	2019-05-24

Vext Science Financials at a Glance

Market Cap

$34.37M

Revenue (TTM)

$52.01M

Net Income (TTM)

-$15.70M

EPS (TTM)

-$0.08

P/E Ratio

-2.40

Dividend

$0.00

Beta (Volatility)

0.69 (Low)

Dividend

$0.00

Beta (Volatility)

0.69 (Low)

Price

$0.19

Volume

27,361

Open

$0.19

Price

$0.19

Volume

27,361

Open

$0.19

Previous Close

$0.19

Daily Range

$0.19 - $0.19

52-Week Range

$0.10 - $0.32

Estimated Earnings Date

Aug 19, 2026

Dividend

$0.00

Beta (Volatility)

0.69 (Low)

Price

$0.19

Volume

27,361

Open

$0.19

Previous Close

$0.19

Daily Range

$0.19 - $0.19

52-Week Range

$0.10 - $0.32

Estimated Earnings Date

Aug 19, 2026

VEXTF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vext Science

Vext Science, Inc. operates as a comprehensive enterprise within the United States' cannabis sector, focusing on agricultural technology, services, and property management. The company cultivates, extracts, manufactures, and distributes a variety of THC and CBD products, including vape cartridges, concentrates, and edibles.

Products and Services

THC and CBD products under Vapen and Pure Touch Botanicals brands
Retail dispensaries and wholesale distribution of cannabis-derived products
Diverse selection of infused edibles through Vapen Kitchens

Growth Outlook

Revenue increased to $11.99 million in Q1 2026, showing strong demand
Gross profit margin improved to 12.9% in Q1 2026, indicating operational efficiency
Expansion of product lines expected to drive future revenue growth

Financial Highlights

Trailing twelve months revenue of $54.5 million, reflecting consistent sales performance
Operating cash flow of $1.59 million in Q1 2026, demonstrating positive cash generation
Current ratio of 0.62, indicating manageable short-term liabilities

Vext Science, Inc. has established itself as a key player in the cannabis industry, leveraging its expertise in cultivation and product development. The company's diverse product offerings and retail presence position it well for future growth. Recent financial performance highlights a positive trend in revenue and operational efficiency, suggesting a solid foundation for potential investors. The focus on expanding product lines and improving gross profit margins further enhances the company's growth prospects.

AI Generated • Aug 12, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Eric Offenberger, CPA

Website

www.vextscience.com

Headquarters

Phoenix, AZ 85019, CA

VEXTF Financials

Key Financial Metrics (TTM)

Gross Margin

23.83%

Operating Margin

-15.25%

Net Income Margin

-30.20%

Return on Equity

-25.19%

Return on Capital

-10.36%

Return on Assets

-13.36%

Earnings Yield

-41.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$34.37M

Shares Outstanding

185.79M

Volume

27.36K

Avg. Volume

29.08K

Financials (TTM)

Gross Profit

$12.39M

Operating Income

-$7.93M

EBITDA

$9.19M

Operating Cash Flow

$10.27M

Capital Expenditure

-$3.18M

Free Cash Flow

$7.09M

Cash & ST Invst.

$5.56M

Total Debt

$34.08M

Vext Science Performance Analysis

Vext Science annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 35,410,636	-4.9%
2023	2023-12-31	USD 34,812,311	-1.7%
2024	2024-12-31	USD 35,997,581	3.4%
2025	2025-12-31	USD 51,367,000	42.7%

Vext Science sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	16.0%
Q3	2025-09-30	-5.5%
Q4	2025-12-31	10.0%
Q1	2026-03-31	-14.0%

Vext Science annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD 0.08	129.3%
2023	2023-12-31	USD 0.03	-65.9%
2024	2024-12-31	USD -0.09	N/A
2025	2025-12-31	USD -0.07	-21.9%

Vext Science sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	54.8%
Q3	2025-09-30	-72.1%
Q4	2025-12-31	-449.5%
Q1	2026-03-31	93.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$11.99M

+3.7%

Gross Profit

$1.55M

-31.9%

Gross Margin

12.94%

N/A

Market Cap

$34.37M

N/A

Market Cap/Employee

$198.68K

N/A

Employees

173

N/A

Net Income

-$879.64K

+73.6%

EBITDA

$2.32M

+130.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$5.56M

+15.2%

Total Debt

$34.08M

-8.8%

Accounts Receivable

$1.71M

-5.9%

Inventory

$8.60M

-17.2%

Long Term Debt

$25.68M

-22.8%

Short Term Debt

$8.38M

+103.7%

Return on Assets

-13.36%

N/A

Return on Invested Capital

-8.80%

N/A

Free Cash Flow

$1.18M

-48.0%

Operating Cash Flow

$1.59M

-48.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CXXIFC21 Investments Inc.

CXXIFC21 Investments Inc.$0.27+0.48%

LEEEFLeef Brands Inc.

LEEEFLeef Brands Inc.$0.19+0.79%

MRMDMariMed Inc.

MRMDMariMed Inc.$0.07-4.02%

ELIXFElixxer Ltd.

ELIXFElixxer Ltd.$0.03+0.00%

DXBRFBellRock Brands Inc.

DXBRFBellRock Brands Inc.$0.00+0.00%

TCNAFTransCanna Holdings Inc.

TCNAFTransCanna Holdings Inc.$0.00+0.00%

FLOOFFlower One Holdings Inc.

FLOOFFlower One Holdings Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SMCISuper Micro Computer

SMCISuper Micro Computer$35.74+0.13%

INTCIntel

INTCIntel$101.04+0.03%

NOKNokia

NOKNokia$10.48+0.11%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$138.88+0.04%

CRWVCoreWeave

CRWVCoreWeave$106.69+0.18%

NVDANvidia

NVDANvidia$224.37+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$7.89-0.05%

Questions About VEXTF

What is the current price of Vext Science?

Vext Science is trading at $0.19 per share.

What is the 52-week range for Vext Science?

Over the past 52 weeks, Vext Science has traded between $0.10 and $0.32.

How much debt does Vext Science have?

As of the most recent reporting period, Vext Science reported total debt of $33.97M.

How much cash does Vext Science have on hand?

Vext Science reported $5.54M in cash and cash equivalents in its most recent financial results.

What is Vext Science’s dividend yield?

Vext Science does not currently have a dividend yield.

Vext Science(OTC) VEXTF

Vext Science Financials at a Glance

VEXTF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Vext Science

VEXTF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Vext Science Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VEXTF

What is the current price of Vext Science?

What is the 52-week range for Vext Science?

How much debt does Vext Science have?

How much cash does Vext Science have on hand?

What is Vext Science’s dividend yield?

Premium Investing Services